Core Viewpoint - The company focuses on the smart healthcare sector, aiming for high-quality development through product iteration, market expansion, cost optimization, and resource integration [2] Group 1: Business Strategy - The company is enhancing its profitability by improving its product offerings in AI medical record quality control, emergency critical care, and closing data loops for perioperative care [2] - The company supports intelligent review of medical insurance DRG/DIP and intelligent triage and guidance as part of its product strategy [2] Group 2: Market Focus - The company plans to strengthen regional market collaboration to improve profitability as a core objective [2] - The company commits to regularly disclosing significant business progress to protect the rights of all shareholders [2]

声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 来源：市场资讯 针对上述提问，荣科科技回应称："投资者您好！公司聚焦智慧医疗主赛道，通过产品迭代、市场拓 展、成本优化与资产整合，逐步提升盈利能力，实现高质量发展。公司产品布局将继续在AI病历质 控、急诊重症临床、打通急诊重症围术期数据闭环，支持医保DRG/DIP智能审核、智能分诊导诊，并加 大区域市场协同力度，以改善盈利为核心目标，定期披露重大业务进展，切实维护全体股东权益。感谢 您的关注！" 有投资者在互动平台向荣科科技提问："请问贵公司以现时的主业怎样提高业绩？用怎样的方式来回报 投资者？" ...

每经AI快讯，荣科科技（300290.SZ）1月22日在投资者互动平台表示，当前AI业务收入占比较低，是 行业发展规律与公司产品研发、市场推进节奏共同作用的结果，并非商业化能力存在重大短板。公司 AI业务仍处于战略投入与市场拓展期，已形成 AI 病历质控、重症智能体、DRG/DIP 医保控费系统等场 景产品矩阵。未来公司将持续加大 AI 研发投入，并依托现有医疗机构客户基础，加速业务规模化扩 张。 （文章来源：每日经济新闻） ...

Core Viewpoint - The company is committed to deepening its presence in the smart health sector, leveraging artificial intelligence and computing power to enhance healthcare and urban management services [1][2] Group 1: Business Overview - The company has developed a comprehensive intelligent solution covering pre-hospital emergency, clinical diagnosis, and logistics management in the smart healthcare field, serving over 5,000 medical institutions and more than 80% of the top 100 hospitals [1] - In the smart city and energy management sectors, the company utilizes digital twin and edge computing technologies to create platforms like "Rongjia Houqin™" for energy control and safety operations in urban governance [1] Group 2: Financial Performance - In the first half of 2025, the company reported revenue of 292 million yuan, a year-on-year decrease of 7.01%, and a net loss of 272.29 million yuan, with losses expanding by 576.78% compared to the previous year [2] - For the first nine months of 2025, the company achieved revenue of 162 million yuan, a year-on-year decline of 4.49%, and a net loss of 446.11 million yuan, with losses increasing by 378.82% year-on-year [2]